NAFLD (see DM) Flashcards

1
Q

complications of NAFLD (2)

A

cirrhosis; hepatocellular carcinoma (HCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the 2 types of NAFLD

A
  1. NAFL - excess fat, doesn’t cause inflammation of scarring
  2. NASH (non-alcoholic steato-hepatitis) - lobular inflammation, scar tissue and hepatocyte ballooning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

investigations for NAFLD (4)

A
  1. ALT and GTT - raised
  2. AST:ALT ratio - a ration <0.8 exludes advanced fibrosis
  3. US - can detect steatosis (if >33% of hepatocytes are steatotic)
  4. non-invasive screening
  5. ferratin - marginally raised
  6. liver biopsy - gold standard for staging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

scoring systems for NALFD (2)

A
  1. NAFLD fibrosis score
  2. Fib-4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is steatosis

A

a largely harmless build-up of fat in the liver cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

steatosis vs steatohepatitis

A

steatosis - simple fatty liver;
steatohepatitis - a state of hepatocellular inflammation and damage in response to the accumulated fat (i.e. advanced stage fatty liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what test can be used to distinguish liver firbrosis levels

A

elastography - measures shear wave (pulsed US) in liver, fibrotic tissue has reduced elasticity and so gives different signals compared to non fibrotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the gold standard test for NAFLD diagnosis and staging

A

liver biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

simple steatosis histology appearance (3)

A
  1. macrovesicular;
  2. no inflammatory infiltrate;
  3. perivenular pattern
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NASH histology appearance

A
  1. fatty change
  2. ballooned hepatoytes
  3. mallory’s hyaline (irregular, ropelike eosinophilic intracytoplasmic strings that represent aggregates of cytokeratin intermediate filaments)
  4. neutrophilic infiltrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what histological feature is more common in NAFLD vs alcoholic liver disease

A

nuclear vacuolation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what gene is associated with increased NAFLD risk

A

PNPLA3 - codes for an adipose triglyceride lipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

causes of liver steatosis

A
  1. hep C
  2. alcohol excess
  3. genetic disorders (e.g. abetolipoprotienanemia, glycogen storage disease)
  4. medications (e.g. amiodarone, mtx)
  5. hypothyroidism
  6. other (rarer causes e.g. wilson’s disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the main cause for NAFLD

A

metabolic associated dysfunction -> liver insulin resistance, adipose insulin resistance etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the 4 main components to NAFLD mgx

A
  1. life style modification
  2. targeting components of metabolic syndrome
  3. liver directed pharmacotherapy
  4. managing complications of cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how should lifestyle be modified in NAFLD mgx (4)

A
  1. calorie restricted diet, avoid fats, simple carbs and sweetened drinks
  2. increase exercise
  3. advise weight loss
  4. coffee - decreases the risk of liver cancer
17
Q

what are the (pharmaco)therapies for the liver in NAFLD mgx (3)

A
  1. bariatric surgery (unless they hv portal hypertension/cirrhosis)
  2. glitazones
  3. vitamin E
18
Q

how should metabolic syndrome components be trageted in NAFLD mgx (3)

A
  1. DM control - metformin, pioglitazone, GLP-1 analogues
  2. HTN control - ACEi/ARB should be first line as it also haa anti-fibrotic effects
  3. OSHA treatment
19
Q

treatment of complicated cirrhosis in NAFLD (4)

A
  1. varices surveillance
  2. HCC surveillance
  3. osteoporosis mgx
  4. liver transplantation